touchONCOLOGY were honoured to meet Denis Lacombe, Director General, European Organisation for Research and Treatment of Cancer (EORTC), at the ECCO 2019 European Cancer Summit in Brussels to discuss the latest exciting updates in clinical cancer research across Europe: do we need to change tracks?
Questions
1. What are the key recent advances in clinical cancer research in Europe – how will they impact treatments for patients? (0:08)
2. How has the development of anti-cancer treatments changed in recent years and how is it continuing to change? (0:40)
3. Despite recent advances, is the current clinical research in cancer in Europe addressing the right issues or pursuing the right targets? (1:38)
4. What is the European Organisation for Research and Treatment of Cancer (EORTC) doing to address the difficulties in developing new cancer therapies and make them available to patients more quickly? (2:38)
5. Given the ongoing pace of progress of clinical cancer research and treatment developments, do you feel optimistic that the prognosis for many patients with cancer is improving and will it continue to do so into the future? (3:44)
Denis Lacombe has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
